Overview

Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy

Status:
Completed
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of gemcabene on LDL-C and other lipid parameters in hypercholesterolemic patients on a stable dose of a statin.
Phase:
Phase 2
Details
Lead Sponsor:
Gemphire Therapeutics, Inc.
NeuroBo Pharmaceuticals Inc.
Treatments:
Hydroxymethylglutaryl-CoA Reductase Inhibitors